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described wound bed preparation (WBP) as an 
essential element for obtaining maximal benefits 
from advanced wound care products, i.e. if the 
wound was not ‘prepared’ properly first, then 
it followed that whatever new technology was 
applied to the wound would not work. 
The concept of WBP was quickly adopted, 
and was the subject of a major symposium in 
2000, where the definition was extended to 
include ‘removing the barriers to healing’ (Cherry 
et al, 2001). The annual meeting of European 
Tissue Repair Society in 2001 also included a 
satellite symposium on WBP, which resulted in 
a further publication about the use of two new 
technologies (which included cadexomer iodine 
and negative pressure wound therapy [NPWT]) in 
WBP (Falanga and Harding, 2002).
WBP was again the focus of a meeting attended 
by a group of wound care experts in 2002, entitled 
the ‘Wound Bed Advisory Board’ (Schultz et al, 
TIME (Tissue, Inflammation, Moisture, Edges) is a concept that can be used to explain wound bed preparation as an important 
competency of wound management. It has 
become clear that healing can be improved 
through wound bed preparation. This preparation 
includes attention to non-viable tissue, control 
of bioburden and inflammation and moisture 
balance, and stimulation of wound edges to 
facilitate epithelial migration. 
According to Harries et al (2016), the concept 
of ‘wound bed preparation’ was first used by 
Schultz et al (2003). In fact, the term had been 
coined by Sibbald et al (2000), who described it 
as a changing paradigm linking treatment to the 
cause and focusing on three components of local 
wound care: debridement, wound-friendly moist 
interactive dressings, and bacterial balance. The 
term was discussed in 2000, in a Wound Repair 
and Regeneration editorial by Falanga (2000). He 
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TIME (Tissue, Inflammation, Moisture, Edges) and other similar wound 
assessment tools are based on the concept of wound bed preparation. A 
survey was developed to explore the role and utility of wound assessment 
tools in current wound care practice. The survey was answered by attendees 
of the European Wound Management Association (EWMA) 2018 conference 
in Krakow, Poland. Out of 300 attendees invited to answer the survey, 250 
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based on the answers of 196 questionnaire. TIME is the most commonly 
used wound assessment tool in Europe. Despite clinicians being aware of 
frameworks for wound bed assessment, 40% of respondents did not use 
them, and those who used them did so in very variable forms. Data showed 
variability about beliefs and unbalanced implementation of therapeutic 
decisions. Variation in wound size and in the characteristics of the wound bed 
were considered the main factors for the assessment of wound progression. 
Ideally, assessment tools should be unambiguous, easy to teach, easy to 
implement by a large base of HCPs and carers, and should guide the clinician 
consistently through assessment and reassessment processes towards the 
best therapeutic decision.
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2003). They reported that before deciding on local 
wound applications, it was vital to consider the 
possible causes of a non-healing wound and to 
review and correct, if possible, patient factors that 
may impede healing, by: assessing and correcting 
causes of tissue damage; ensuring adequate 
blood supply; and assessing and monitoring 
wound characteristics.
A key message from this group was that 
chronic wounds needed to be managed in a 
different way to acute wounds to optimise their 
healing. The Advisory Board went on to define 
WBP as: “The management of the wound to 
accelerate endogenous healing or to facilitate 
the effectiveness of other therapeutic measures” 
(Schultz et al, 2003). Their key paper revisited 
the concepts first suggested by Sibbald et al 
(2000), while agreeing that a fourth component 
needed to be added to the observations — non-
advancing or undermined epidermal margin. 
They produced a table to illustrate the principles 
of WBP, including the four components of TIME, 
although the actual acronym did not appear in 
the paper, as the fourth component did not start 
with an ‘E’.
A further paper from the same Advisory Board 
in 2004 appears to be the first where the actual 
term TIME is used in several places (Schultz et 
al, 2004). In this paper, the fourth component 
became ‘Edge of wound — non-advancing 
or undermined.’ This change in terminology is 
recognised by the European Wound Management 
Association (EWMA) wound bed preparation 
editorial advisory board, in the EWMA position 
document of  the same year (EWMA, 2004). 
In 2012, the entire TIME concept was reviewed, 
under the auspices of the International Wound 
Infection Institute (IWII; Leaper et al, 2012). 
Their purpose was to examine how new data 
and evidence generated in the intervening 
decade affected the original concepts of TIME, 
and how it was translated into current best 
practice. Four developments were singled out: 
recognition of the importance of biofilms; use 
of NPWT; evolution of topical antiseptic therapy 
as dressings; and expanded insight of the role of 
molecular biological processes in chronic wounds.
Perhaps the main change was to the letter 
‘E’ component, which became “Edge of wound: 
assessment of non-advancing or undermined 
wound edges (and state of the surrounding skin).” 
This was the first occasion where a component 
was to be assessed that was not actually a part 
of the wound. The IWII concluded that TIME was 
still relevant and with continuing important 
developments that incorporated new evidence 
into the model. The principles of wound bed 
preparation have also been applied for the 
development of other assessment tools, some of 
them inspired directly from TIME.
Given the apparent wide use of TIME as a 
concept for effective WBP, we developed a 
survey to explore current practice on standard 
wound care and the use of wound-assessment 
frameworks to identify ways for improvement 
in wound care diagnosis, management and 
healing outcomes. 
Methods and results
The survey was undertaken involving attendees 
at the EWMA conference, held in Krakow, 
Poland, in May 2018. It included 20 questions, 
including a screening section of four questions 
and the questionnaire itself (16 questions) 
exploring attitudes and clinical practice in chronic 
wound care. The survey was presented in an 
electronic form (tablet) and took, on average, 7 
minutes to complete.
Three hundred participants were invited to 
participate. Out of these, 50 were excluded after 
the screening section and 250 completed the 
questionnaire. The professional categories of 
this group are presented in Figure 1.  The ‘other’ 
category included educators, researchers, medical 
students, infection control nurses, microbiologists, 
biophysicists and laboratory specialists.
Survey participants were from five continents 
(Europe 68%, Asia 23%, North America 4%, Africa 
4% and South America 1%), including 52 different 
countries. The most highly represented countries 
in the survey were the United Kingdom 13%, 
Poland 8%, Italy 5% and the Netherlands 5%.
Over 74% of respondents (n=186) were 
responsible for the clinical management of 
patients. A similar number of respondents (n=187) 
were involved in or directly responsible for 
therapeutic decisions related to wound care.
Figure 1. Distribution of 
respondents by profession.
■ Physician 11%■ Surgeon 16%
■ Podiatrist 3%
■ Other 24%■ General Nurse 8%
■ Dermatologist 2%
■ Wound Care Nurse 36%
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Care Society, WIFI (Wound Ischaemia and Foot 
Infection), University of Texas classification, and 
Welsh framework.
To the question ‘How do you document the 
progression of wound healing in your standard 
clinical practice?’ Seventy percent of respondents 
(n=134) use photographic records, 60% (n=118) 
use electronic records and 45% (n=89) use paper 
records. Thirty-six percent (n=71) reported using 
only a single type of record and 64% (n=125) the 
use of two or more types of records.
Answers to the question ‘What do you 
consistently document in wound management in 
your standard clinical practice?’ are presented in 
Figure 3. 
Other items mentioned by some of the 
respondents included: the amount of exudate and 
odour, the description of surgical treatment, the 
therapeutic plan, and demographic data.
To the question ‘Which are the most important 
factors for the improvement of wound healing and 
patient outcomes?’, answers are provided in Table 1. 
To the question about the importance of 
debridement as a key element in standard care 
protocols, 81% (n=159) considered this ‘highly 
important’, 16% (n=31) ‘quite important’ and 3% 
(n=6) ‘important’.
Debridement techniques reported as the more 
frequently used were autolytic 64% (n=125), 
mechanical 60% (n=118), surgical in theatre 49% 
(n=96), and sharp 46% (n=78). Multiple answers 
were possible for this question.
To the question ‘In your clinic, on which wound 
is sharp debridement used?’ Sixty-eight percent 
of respondents (n=133) stated diabetic foot ulcers 
(DFU), 55% (n=107) for pressure ulcers (PU) and 
only 42% (n=82) in venous leg ulcers (VLU). Other 
conditions less frequently mentioned included: any 
other wound type, which contained necrotic tissue 
and complicated surgical wounds.
To the question ‘How do you identify the wound 
is infected?’ 95% of participants answered clinical 
signs and symptoms of infection, in addition, 61% 
mentioned the necessity of confirmation through 
swab/biopsy/tissue culture.
Figure 4 presents the distribution of answers to 
the question, in your opinion how many chronic 
wounds contain biofilm? Answers to the question 
‘How do you know/identify biofilm is present in 
a wound?’ included (multiple answers possible): 
delayed healing 88% (n=173), recurrent infection 
60% (n=118), history of failure to previous 
antimicrobial treatment 42% (n=82), persistent 
level of inflammation 41% (n=80) and absence of 
response to antibiotics 40% (n=38).
Answers to the question ‘What is the one-key 
measurement you use to decide wound healing 
Fifty-four respondents out of 250 did not 
complete the questionnaire in full. These were 
considered invalid as they showed different levels 
of data missing. Unless expressly indicated, the 
analysis corresponds to the data from 196 fully 
completed questionnaires.
Forty-one percent of respondents (n=81) had 
seen and treated more than 40 patients over the 
6 months preceding the survey. Assessment tool/
frameworks most commonly used are presented 
in Figure 2. 
Among the users of assessment frameworks, 
the most frequently used tool was TIME, by 57% 
(n=128) of respondents. Seventy-two percent 
of TIME users were from Europe. The category 
‘others’ included: MOIST (Management of exudate, 
Oxygen, Infection control, Support, and Tissue 
management), TIMES (Tissue Inflammation, 
Moisture, Edges, Surrounding skin), CAWC 
(Canadian Association of Wound Care), Wound 
Figure 2. Wound assessment tools currently in use.
Figure 3. What data do you record as part of wound assessment?
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through associated ideas, such as WB preparation, 
granulation, colour, tissue type or tissue change. 
Other less frequent answers included general 
concepts, such as healing, wound progression, 
progress of healing, wound reassessment and 
clinical condition. Answers also included individual 
factors, such as smell, moisture and exudate.
To the question ‘How long do you wait before 
referring to other healthcare professionals (HCP)?’ 
Answers were surprisingly variable, with 99 (52%) 
respondents providing an answer in days, 83 
(43%) in weeks and 10 (5%) in months. Detailed 
information is presented in Figure 5. Two thirds 
of respondents proceeding to immediate referral 
were physicians and one third wound care nurses. 
The distribution of HCP having answered in 
weeks showed a similar distribution of nurses 
and physicians.
In response to the question ‘How long do you 
wait before trying a new product or therapeutic 
approach when a wound is not healing?’, 31 
(16.5%) answers were in days, 133 (68%) in 
weeks and 30 (15.5%) in months. The most 
frequent answer was 2 weeks; details of which are 
presented in Figure 6. To the question ‘How do you 
assess comorbidities?’, 54% (n=109) stated they 
used their local questionnaire, 26% (n=52) stated 
they would perform the assessment on an ad-
hoc basis. Other answers less frequent included: 
patient records, as part of a holistic assessment, 
clinical history and assessment on admission.
To the question ‘Do you use a framework/
wound care algorithm to help you choose an 
appropriate dressing?’, 61% (n=120) answered in 
the affirmative. Answers to the question ‘What 
type of information would be beneficial to get 
from a framework/algorithm?’ are presented in 
Figure 7. 
Discussion and conclusions
This survey can be considered a snapshot of 
current beliefs in clinical practice among wound 
care experts, regarding wound assessment and 
wound bed preparation. This work was not 
intended to assess comparatively the utility of 
different tools available; instead, the authors 
wanted to explore their general role in current 
wound care practice.
The survey demonstrated that TIME is the most 
commonly used wound assessment tool in Europe. 
Results established that despite clinicians being 
aware of frameworks for wound bed assessment, 
40% of respondents did not use them, and those 
who used them did so in very variable forms. 
Further research would be needed to establish 
how wound assessment tools are used in other 
geographic areas. 
is going in the right direction?’ included mainly 
wound size 43% (n=83) and wound bed status 
28% (n=55). Size was mentioned either in isolation, 
or in combination with other factors, such as 
shrinking, reduction, decrease, and even more 
unspecific, as part of an associated idea, such as 
length, ruler, measuring tape and measurement. 
Wound bed status was mentioned alone or 
Figure 4. What percentage of chronic wounds contain biofilm?
Figure 5. When would you refer to another healthcare professional?
Table 1. Most important factors influencing healing outcomes.
Factors Number of respondents
Infection and Inflammation 158 (81%)
Wound bed tissue type 137 (70%)
Moisture balance in wounds 137 (70%)
Improving patient compliance to the treatment 94 (48%)
Initial holistic patient assessment 88 (45%)
Wound edges 87 (44%)
Reassessment of the therapeutic plan and  wound evolution 84 (42%)
Addressing underlying health conditions 82 (41%)
0
5  (3%)
14  (7%)
57  (29%)
89  (45%)
31  (16%)
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100
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wound assessment and reassessment. Variation 
in wound size and in the characteristics of the 
wound bed were considered the main factors 
for the assessment of wound progression.
The importance of early intervention and 
continuous assessment were considered key 
drivers to improving wound care and healthcare 
outcomes using either a validated assessment 
tool or clinical judgement. 
It was also clear that clinicians expect to 
obtain multiple benefits from the use of a 
validated tool. Results from what is expected 
of wound assessment tools showed that 
ideally, they should be unambiguous, easy 
to teach, easy to implement by a large base 
of HCPs and carers, and should guide the 
clinician consistently through assessment 
and reassessment processes towards the best 
therapeutic decision.
As the survey revealed a disjointed and 
unbalanced use of validated assessment tools, 
identifying ways to implement a permanent 
and consistent use of assessment tools requires 
adapted education, further research and 
adjustment efforts to allow for simplification 
and consistency going forward.   Wint
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Bioburden and biofilm are concepts 
integrated in clinical practice, however, the 
survey revealed an apparent misperception 
about the presence and role of biofilms in 
chronic wounds. About 40% of respondents 
underestimated the amount of chronic wounds 
containing biofilm (Malone et al, 2017).
Recommendations for wound bed 
preparation put forward the value of proactive 
mechanical debridement as a way to accelerate 
healing and managing biofilm at the same 
time. In spite of recognising the benefits 
of other forms of debridement, autolytic 
continues to be the most commonly used 
debridement technique. Reasons for this may 
include education/training, and certification/
authorisation factors.
The survey showed also evidence of variability 
regarding timings used by clinicians to 
implement changes into therapeutic plans or to 
refer patients for specialised care. Despite this 
situation, there was consensus on the need for 
Figure 6. How long do you wait before trying a new product or therapeutic approach when a 
wound is not healing?
Figure 7. What information would you like to obtain from an assessment framework?
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